The thrombophilia screen included functional chromogenic assays for antithrombin, Protein C and Protein S. Activated Protein C resistance was assessed with molecular confirmation of Factor V Leiden when indicated. This evidence concerns the gene F5 and Rare hereditary thrombophilia.